| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 144, 393-403, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
JA Ember, SD Sanderson, TE Hugli and EL Morgan
Scripps Research Institute, La Jolla, CA 92037.
Interleukin-8 (IL-8) is an important mediator of inflammation and has been shown to be a potent chemotactic/cell activator for polymorphonuclear neutrophils (PMNs). T lymphocytes, and basophils. Cellular sources of IL-8 include monocytes, PMNs, endothelial cells, epithelial cells, and keratinocytes when stimulated by factors such as lipopolysaccharide, IL-1, and tumor necrosis factor-alpha. This report demonstrates that C5a, in addition to being a direct mediator of inflammation, can induce both IL-8 synthesis and high levels of release from monocytes. Natural human C5a and a synthetic C-terminal analogue peptide of C5a each induced IL-8 synthesis and release from CD14+ human peripheral blood mononuclear cells. Antigenic reactivity based on enzyme-linked immunosorbent assay gave evidence that IL-8 was present in the culture supernatants of stimulated peripheral blood mononuclear cells. Proof that supernatant levels of IL-8 attain biologically significant quantities was provided by human PMN chemotaxis assays. The quantity of IL-8 recovered from C5a-activated monocytes in peripheral blood mononuclear cells is up to 1,000-fold greater than that released from comparable numbers of PMNs under similar conditions. Therefore, IL- 8 released from C5a-activated monocytes may play a significant role in expanding and prolonging cellular infiltration and activation at sites of infection, inflammation, or tissue injury. This observation suggests an important humoral amplification loop for inflammatory events involving both complement activation and cytokine release.
This article has been cited by other articles:
 |
|
 |
|
  J. Wehner, C. N. Morrell, T. Reynolds, E. R. Rodriguez, and W. M. Baldwin III Antibody and Complement in Transplant Vasculopathy Circ. Res., February 2, 2007; 100(2): 191 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. March, L. M. Proctor, M. J. Stoermer, R. Sbaglia, G. Abbenante, R. C. Reid, T. M. Woodruff, K. Wadi, N. Paczkowski, J. D. A. Tyndall, et al. Potent Cyclic Antagonists of the Complement C5a Receptor on Human Polymorphonuclear Leukocytes. Relationships between Structures and Activity Mol. Pharmacol., April 1, 2004; 65(4): 868 - 879. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Wehlin, J. Vedin, J. Vaage, and J. Lundahl Activation of complement and leukocyte receptors during on- and off pump coronary artery bypass surgery Eur. J. Cardiothorac. Surg., January 1, 2004; 25(1): 35 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Soruri, J. Riggert, T. Schlott, Z. Kiafard, C. Dettmer, and J. Zwirner Anaphylatoxin C5a Induces Monocyte Recruitment and Differentiation into Dendritic Cells by TNF-{alpha} and Prostaglandin E2-Dependent Mechanisms J. Immunol., September 1, 2003; 171(5): 2631 - 2636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Soruri, Z. Kiafard, C. Dettmer, J. Riggert, J. Kohl, and J. Zwirner IL-4 Down-Regulates Anaphylatoxin Receptors in Monocytes and Dendritic Cells and Impairs Anaphylatoxin-Induced Migration In Vivo J. Immunol., March 15, 2003; 170(6): 3306 - 3314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Afanasyeva and N. R. Rose Cardiomyopathy Is Linked to Complement Activation Am. J. Pathol., August 1, 2002; 161(2): 351 - 357. [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Ye Regulation of nuclear factor {kappa}B activation by G-protein-coupled receptors J. Leukoc. Biol., December 1, 2001; 70(6): 839 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Ulrich, W. Cieplak, N. J. Paczkowski, S. M. Taylor, and S. D. Sanderson Induction of an Antigen-Specific CTL Response by a Conformationally Biased Agonist of Human C5a Anaphylatoxin as a Molecular Adjuvant J. Immunol., May 15, 2000; 164(10): 5492 - 5498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. KALLIO, K. B. LEMSTRÖM, P. J. HÄYRY, U. S. RYAN, and P. K. KOSKINEN Blockade of Complement Inhibits Obliterative Bronchiolitis in Rat Tracheal Allografts Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1332 - 1339. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Christophe, M.-J. Rabiet, M. Tardif, M.-D. Milcent, and F. Boulay Human Complement 5a (C5a) Anaphylatoxin Receptor (CD88) Phosphorylation Sites and Their Specific Role in Receptor Phosphorylation and Attenuation of G Protein-mediated Responses. DESENSITIZATION OF C5a RECEPTOR CONTROLS SUPEROXIDE PRODUCTION BUT NOT RECEPTOR SEQUESTRATION IN HL-60 CELLS J. Biol. Chem., January 21, 2000; 275(3): 1656 - 1664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wittmann, J. Zwirner, V.-A. Larsson, K. Kirchhoff, G. Begemann, A. Kapp, O. Gotze, and T. Werfel C5a Suppresses the Production of IL-12 by IFN-{gamma}-Primed and Lipopolysaccharide-Challenged Human Monocytes J. Immunol., June 1, 1999; 162(11): 6763 - 6769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Hsu, M. Wang, D. D. Browning, N. Mukaida, and R. D. Ye NF-{kappa}B Activation Is Required for C5a-Induced Interleukin-8 Gene Expression in Mononuclear Cells Blood, May 15, 1999; 93(10): 3241 - 3249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nataf, N. Davoust, R. S. Ames, and S. R. Barnum Human T Cells Express the C5a Receptor and Are Chemoattracted to C5a J. Immunol., April 1, 1999; 162(7): 4018 - 4023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fayyazi, R. Sandau, L. Q. Duong, O. Gotze, H. J. Radzun, S. Schweyer, A. Soruri, and J. Zwirner C5a Receptor and Interleukin-6 Are Expressed in Tissue Macrophages and Stimulated Keratinocytes but not in Pulmonary and Intestinal Epithelial Cells Am. J. Pathol., February 1, 1999; 154(2): 495 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Fischer, M. A. Jagels, and T. E. Hugli Regulation of IL-6 Synthesis in Human Peripheral Blood Mononuclear Cells by C3a and C3adesArg J. Immunol., January 1, 1999; 162(1): 453 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. E. Hopken, B. Lu, N. P. Gerard, and C. Gerard Impaired Inflammatory Responses in the Reverse Arthus Reaction Through Genetic Deletion of the C5a Receptor J. Exp. Med., August 29, 1997; 186(5): 749 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Finn, B. P. Morgan, N. Rebuck, N. Klein, C. A. Rogers, M. Hibbs, M. Elliott, D. F. Shore, T. W. Evans, S. Strobel, et al. EFFECTS OF INHIBITION OF COMPLEMENT ACTIVATION USING RECOMBINANT SOLUBLE COMPLEMENT RECEPTOR 1 ON NEUTROPHIL CD11B/CD18 AND L-SELECTIN EXPRESSION AND RELEASE OF INTERLEUKIN-8 AND ELASTASE IN SIMULATED CARDIOPULMONARY BYPASS J. Thorac. Cardiovasc. Surg., February 1, 1996; 111(2): 451 - 459. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
